Antifungal drug susceptibility testing

David W. Warnock*, Elizabeth Johnson

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

1 Citation (Scopus)

Abstract

With the development of a standardized broth macrodilution reference method for in-vitro testing of Candida spp. and Cryptococcus neoformans, it is now possible to correlate antifungal drug minimum inhibitory concentrations with clinical outcome, and to establish interpretive breakpoints for different infections. More convenient methods (broth microdilution and agar diffusion) of testing are now being evaluated by comparison with the standard reference method, and modifications of this procedure also appear promising for the in-vitro testing of filamentous fungi.

Original languageEnglish
Pages (from-to)444-448
Number of pages5
JournalCurrent Opinion in Infectious Diseases
Volume10
Issue number6
DOIs
Publication statusPublished - 1997

Fingerprint

Dive into the research topics of 'Antifungal drug susceptibility testing'. Together they form a unique fingerprint.

Cite this